BioXcel Therapeutics, Inc. (BTAI) Stock buybacks
BioXcel Therapeutics, Inc. (BTAI) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$9.0MFY2021
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $9.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice